Valuation (84%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.06 | N/A |
| PEG Ratio (TTM) | 0.08 | N/A |
| P/S Ratio (TTM) | 7.70 | N/A |
| P/B Ratio (TTM) | 1.05 | N/A |
| P/FCF Ratio (TTM) | 6.15 | N/A |
| Price to 5YR AVG Earnings Ratio | 19.92 | N/A |
| Price to 5YR AVG FCF Ratio | 5.66 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.73% | N/A |
| ROE (TTM) | 13.00% | N/A |
| Net Profit Margin (TTM) | 95.68% | N/A |
| ROIC 5YR AVG | 8.94% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -16.38% | -18.17% | 19.18% |
| Revenue | 10.79% | -18.11% | 20.03% |
| Net Income | -15.57% | -18.63% | 19.13% |
| Cash Flow | -4.46% | 164.83% | 147.86% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.73 | N/A |
| Quick Ratio (TTM) | 0.73 | N/A |
| D/E Ratio (TTM) | 0.00 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.19 | N/A |
| LTL to 5YR AVG FCF | 0.02 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.05% | N/A |